Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


New cannabis player in Aust

Posted 25 February 2021

The lucrative medicinal cannabis market has a surprise new player with Australia's national science agency, CSIRO, securing a licence to develop new products targeting a string of conditions from MS to chronic pain.

In what is being celebrated as a coup for the industry, from today (Thursday) CSIRO is the first and only independent research institute in Australia able to develop drug manufacturing protocols in the medical cannabis space.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas